Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients

Author： Turner Stuart J   Chen Sharon CA   Slavin Monica A   Kong David CM  

Publisher： Informa Healthcare

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.2, 2013-04, pp. : 227-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antifungal Agents in Hematopoietic Stem Cell Transplantation

By  

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 2011-2021

Bentham Science Publishers

Access to resources Recommend Favorite

Busulfan in hematopoietic stem cell transplant setting

By McCune Jeannine S   Holmberg Leona A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 957-969

Informa Healthcare

Access to resources Recommend Favorite

Sexual health in hematopoietic stem cell transplant recipients

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4124-4131

Blackwell Publishing

Access to resources Recommend Favorite

A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties

By  

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2303-2313

Blackwell Publishing

Access to resources Recommend Favorite

Hepatitis B‐related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation

By  

Hematological Oncology (Electronic), Vol. 34, Iss. 3, 2016-09 ,pp. : 140-146

John Wiley & Sons Inc

Access to resources Recommend Favorite